BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12408340)

  • 21. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
    Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT
    Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hep Par 1 expression in carcinoma of the cervix: implications for diagnosis and prognosis.
    Thamboo TP; Wee A
    J Clin Pathol; 2004 Jan; 57(1):48-53. PubMed ID: 14693835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical characterization of canine hyperplastic hepatic lesions and hepatocellular and biliary neoplasms with monoclonal antibody hepatocyte paraffin 1 and a monoclonal antibody to cytokeratin 7.
    Ramos-Vara JA; Miller MA; Johnson GC
    Vet Pathol; 2001 Nov; 38(6):636-43. PubMed ID: 11732796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibody SM047 as an immunohistochemical marker of ovarian adenocarcinoma.
    McCluggage WG; Maxwell P; Veenstra H; Fick CE; Laeng RH; Tiltman AJ
    Histopathology; 2001 Jun; 38(6):542-9. PubMed ID: 11422498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phagocytosis (cannibalism) of apoptotic neutrophils by tumor cells in gastric micropapillary carcinomas.
    Barresi V; Branca G; Ieni A; Rigoli L; Tuccari G; Caruso RA
    World J Gastroenterol; 2015 May; 21(18):5548-54. PubMed ID: 25987778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoreactivity to monoclonal antibody, Hep Par 1, in human hepatocellular carcinomas according to histopathological grade and histological pattern.
    Kumagai I; Masuda T; Sato S; Ishikawa K
    Hepatol Res; 2001 Jul; 20(3):312-319. PubMed ID: 11404191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
    Pitman MB; Triratanachat S; Young RH; Oliva E
    Int J Gynecol Pathol; 2004 Jan; 23(1):58-64. PubMed ID: 14668552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types.
    Fujimoto M; Matsuzaki I; Nishino M; Iwahashi Y; Warigaya K; Kojima F; Ono K; Murata SI
    J Clin Pathol; 2018 Jul; 71(7):600-607. PubMed ID: 29305518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.
    Park SY; Kim HS; Hong EK; Kim WH
    Hum Pathol; 2002 Nov; 33(11):1078-85. PubMed ID: 12454811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
    Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
    Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CEACAM5 has different expression patterns in gastric non-neoplastic and neoplastic lesions and cytoplasmic staining is a marker for evaluation of tumor progression in gastric adenocarcinoma.
    Liu JN; Wang HB; Zhou CC; Hu SY
    Pathol Res Pract; 2014 Oct; 210(10):686-93. PubMed ID: 25042385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An immunohistochemical study of p53 protein in the different histological subtypes of gastric carcinoma.
    Teh M; Lee YS
    Pathology; 1994 Oct; 26(4):432-4. PubMed ID: 7892045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistological evaluation of single small hepatocellular carcinoma with negative staining of monoclonal antibody Hepatocyte Paraffin 1.
    Sugiki T; Yamamoto M; Aruga A; Takasaki K; Nakano M
    J Surg Oncol; 2004 Nov; 88(2):104-7. PubMed ID: 15499598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of a colorectal antigen defined by a new monoclonal antibody, CO-TL1.
    ten Dam GB; Poels LG; Pullens R; Jap PH; van de Molengraft FJ
    Lab Invest; 2004 Sep; 84(9):1160-73. PubMed ID: 15195115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites.
    De Lott LB; Morrison C; Suster S; Cohn DE; Frankel WL
    Arch Pathol Lab Med; 2005 Sep; 129(9):1100-5. PubMed ID: 16119980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system.
    Su MC; Yuan RH; Lin CY; Jeng YM
    Mod Pathol; 2008 Nov; 21(11):1379-86. PubMed ID: 18552820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new tumor-associated antigen defined by a monoclonal antibody directed to gastric adenocarcinoma.
    Watanabe R; Johzaki H; Iwasaki H; Kikuchi M; Ikeda S
    Cancer; 1993 Apr; 71(8):2439-47. PubMed ID: 7680948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nm23 gene expression in gastric carcinoma: an immunohistochemical study.
    Yeung P; Lee CS; Marr P; Sarris M; Fenton-Lee D
    Aust N Z J Surg; 1998 Mar; 68(3):180-2. PubMed ID: 9563444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoreactivity of hepatocyte paraffin 1 monoclonal antibody in cutaneous metastatic tumors.
    Kanitakis J; Chouvet B; Claudy A; Scoazec JY
    Am J Clin Pathol; 2004 Jul; 122(1):85-9. PubMed ID: 15272534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroendocrine differentiation in gastric adenocarcinomas. An immunohistochemical study.
    Blumenfeld W; Chandhoke DK; Sagerman P; Turi GK
    Arch Pathol Lab Med; 1996 May; 120(5):478-81. PubMed ID: 8639052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.